TMEM184B anticorps (C-Term)
Aperçu rapide pour TMEM184B anticorps (C-Term) (ABIN500976)
Antigène
Voir toutes TMEM184B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody detects TMEM184B near C-term.
-
Purification
- Peptide affinity chromatography
-
Immunogène
- TMEM184B antibody was raised against a 15 amino acid peptide near the carboxy terminus of human TMEM184B.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
ELISA. Western blot.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- TMEM184B (Transmembrane Protein 184B (TMEM184B))
-
Autre désignation
- TMEM184B
-
Sujet
- TMEM184B, also known as C22orf5, is a 407 amino acid multi-pass membrane protein and represents a novel gene in the activation of the MAPK signaling pathway. The gene encoding TMEM184B maps to human chromosome 22, mutations in several of the genes in chromosome 22 are involved in the development of autism, schizophrenia, Phelan-McDermid syndrome and Neurofibromatosis type 2, suggesting that TMEM184B may play a role in these syndromes.Synonyms: C22orf5, Putative MAPK-activating protein FM08, Transmembrane protein 184B
-
ID gène
- 25829
-
NCBI Accession
- NP_036396
Antigène
-